Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemoradiation with Hydroxychloroquine for Resectable Pancreatic Cancer
NCT01494155Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2011
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in pancreatic cancer (PC), sponsored by Massachusetts General Hospital. Started Dec 2011; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01494155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494155.